WASHINGTON, D.C. — U.S. Sen. Maggie Hassan (D-NH), a member of the Senate Health, Education, Labor, and Pensions Committee, this week cosponsored bipartisan legislation introduced by U.S. Sens. Ron Wyden (D-OR) and Chuck Grassley (R-IA) that would fix an issue in Medicaid that has allowed pharmaceutical manufacturers to misclassify their drugs and overcharge taxpayers by hundreds of millions of dollars.

The bipartisan Right Rebate Act of 2018 would give Medicaid more tools to go after drug manufacturers that they suspect are misclassifying a drug as a generic when it should be a brand name. When a pharmaceutical company misclassifies a drug as a generic drug as part of the Medicaid Drug Rebate Program, the company can pay less in rebates into the program and cheat taxpayers.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.